Clinical Trial: The Swedish BioFINDER - Primary Care Study

Study Status: RECRUITING
Recruit Status: RECRUITING

Official Title: The Swedish BioFINDER - Primary Care Study

Brief Summary:

The overall aim of the study is to improve the diagnostic accuracy of AD and cognitive impairment in primary care settings to ensure better care and treatment as well as facilitate correct referrals to specialized memory clinics.
The investigators will strive to recruit diverse and representative populations of patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and mild dementia.
The specific aims of the study are to:

  1. Improve the detection of mild cognitive impairment (MCI) and dementia in primary care.
  2. Develop and evaluate cognitive tests, blood-based biomarkers and brain imaging methods that are suitable for accurate and early diagnosis of Alzheimer's disease (AD) in primary care.
  3. To prospectively validate plasma AD biomarkers for diagnosis of patients with cognitive symptoms who are evaluated in primary care.
  4. Determine whether blood AD biomarkers improve patient management in primary care.